Recruiting PHASE3 INTERVENTIONAL 2-arm
NCT07354464
Efficacy of Sphenopalatine Block Compared to Blood Patch in the Management of Post-dural Puncture Headaches (BRECHE)
Sponsor: University Hospital, Clermont-Ferrand
Conditions
PDPH Post Dural Puncture Headache
Interventions
Blood patch Sphenopalatine Ganglion Block
Updated 1 time since 2026 Last updated: Feb 26, 2026 Started: Feb 19, 2026 Primary completion: Feb 29, 2028 Completion: Feb 29, 2028
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This PHASE3 trial investigates PDPH and Post Dural Puncture Headache and is currently actively recruiting participants. University Hospital, Clermont-Ferrand leads this study, which shows 1 recorded version since 2026 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
1 version recorded Recruiting — PHASE3
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- University Hospital, Clermont-Ferrand
Data source: University Hospital, Clermont-Ferrand
For direct contact, visit the study record on ClinicalTrials.gov .